Recognition of non-operating expense (foreign exchange loss), extraordinary gain (subsidy income) and extraordinary loss (loss on compression of fixed assets)
The filing company (NIPRO CORPORATION) and its consolidated subsidiary ニプロファーマ株式会社
The Omi Plant of ニプロファーマ株式会社 and construction of a manufacturing building for cefem antibacterial double-bag formulations
The foreign exchange loss resulted from fluctuations in exchange rates during the cumulative consolidated period for the fiscal year ending March 2026. The subsidy income resulted from the project being selected as eligible for a subsidy administered by the Ministry of Economy, Trade and Industry and the subsequent grant of the subsidy. The loss on compression of fixed assets resulted from the application of compression accounting using the direct reduction method in connection with the subsidy grant.
Foreign exchange loss of ¥4,191 million (non-operating expense), government subsidy of ¥4,073 million (extraordinary gain), and loss on compression of fixed assets of ¥3,870 million (extraordinary loss)
The cumulative consolidated period for the fiscal year ending March 2026 (1 April 2025 to 31 March 2026) and the consolidated financial results for the fiscal year ending March 2026
Reflected in the “Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)” released today
Related procedures
Ministry of Economy, Trade and Industry (identified as the authority that selected the subsidized project)
| Item | Details |
|---|---|
| Event name | Recognition of non-operating expense (foreign exchange loss), extraordinary gain (subsidy income) and extraordinary loss (loss on compression of fixed assets) |
| Subject Entity | The filing company (NIPRO CORPORATION) and its consolidated subsidiary ニプロファーマ株式会社 |
| Target Locations / Products | The Omi Plant of ニプロファーマ株式会社 and construction of a manufacturing building for cefem antibacterial double-bag formulations |
| Cause | The foreign exchange loss resulted from fluctuations in exchange rates during the cumulative consolidated period for the fiscal year ending March 2026. The subsidy income resulted from the project being selected as eligible for a subsidy administered by the Ministry of Economy, Trade and Industry and the subsequent grant of the subsidy. The loss on compression of fixed assets resulted from the application of compression accounting using the direct reduction method in connection with the subsidy grant. |
| Amount of Impact on Business Performance | Foreign exchange loss of ¥4,191 million (non-operating expense), government subsidy of ¥4,073 million (extraordinary gain), and loss on compression of fixed assets of ¥3,870 million (extraordinary loss) |
| Accounting period in which recognized | The cumulative consolidated period for the fiscal year ending March 2026 (1 April 2025 to 31 March 2026) and the consolidated financial results for the fiscal year ending March 2026 |
| Impact on Earnings Forecast | Reflected in the “Summary of Financial Results for the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)” released today |
| Court or authority | Ministry of Economy, Trade and Industry (identified as the authority that selected the subsidized project) |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The foreign exchange loss resulted from fluctuations in exchange rates during the cumulative consolidated period for the fiscal year ending March 2026. The subsidy income was recognized because the construction of a manufacturing building at the Omi Plant of ニプロファーマ株式会社 for cefem antibacterial double-bag formulations was selected as an eligible project under a subsidy program administered by the Ministry of Economy, Trade and Industry, and the subsidy was granted. The loss on compression of fixed assets resulted from the application of compression accounting using the direct reduction method in connection with the subsidy grant.